BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231127
DTEND;VALUE=DATE:20231201
DTSTAMP:20260516T075559
CREATED:20230803T103428Z
LAST-MODIFIED:20230803T103428Z
UID:37560-1701043200-1701388799@www.pharmajournalist.com
SUMMARY:5th Annual Gene Therapy Analytical Development Summit 2023
DESCRIPTION:Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy\, robust and detailed analytics are the cornerstone of gene therapy development. As regulators scrutinize products more closely\, accurately characterizing gene therapy products and standing behind safety and efficacy is crucial to drug developers bringing gene therapies into and through the clinic. \nIn this context\, the 5th Annual Gene Therapy Analytical Development is returning in 2023\, uniting 400+ analytical experts to explore how the latest analytical methods are being developed and applied to guarantee the quality\, consistency\, safety\, and efficacy of gene therapy products. \nJoin biopharma colleagues specializing in bioassays\, molecular biology\, physicochemical properties\, quality\, process development and regulation across 4 days of niche\, expert presentations\, and dedicated networking opportunities. This is your must-attend meeting to collaborate ideas\, success and challenges to capitalize on the technological advances in analytical development to reach the ultimate goal of bringing safer\, efficacious therapies to patients more quickly and effectively. \nTo know more visit: https://ter.li/qf50s3
URL:https://www.pharmajournalist.com/event/5th-annual-gene-therapy-analytical-development-summit-2023/
LOCATION:Boston Park Plaza\, 50 Park Plaza\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231128
DTEND;VALUE=DATE:20231201
DTSTAMP:20260516T075559
CREATED:20230724T153728Z
LAST-MODIFIED:20230724T153728Z
UID:37515-1701129600-1701388799@www.pharmajournalist.com
SUMMARY:Cell Therapy for Autoimmune Disease Summit
DESCRIPTION:Enter the inaugural Cell Therapy for Autoimmune Disease Summit\, a pioneering platform singularly focused on uniting and empowering this community for the first time. Experts will delve into cutting-edge frontiers of pre-clinical\, translational\, and clinical advancements encompassing all cell-based therapies\, including CAR-T\, Treg\, and MSC\, with the shared objective of developing better therapies for patients with chronic autoimmune diseases. \nDon’t miss out on your opportunity to network with 80+ key opinion leaders including Cabaletta Bio\, Kyverna Therapeutics\, AstraZeneca\, Quell Therapeutics\, Novartis\, and more. Learn more – https://ter.li/6xwjrk
URL:https://www.pharmajournalist.com/event/cell-therapy-for-autoimmune-disease-summit/
LOCATION:Sonesta Philadelphia Rittenhouse Square\, 1800 Market Street\, Philadelphia\, PA\, 19103\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231128
DTEND;VALUE=DATE:20231201
DTSTAMP:20260516T075559
CREATED:20230822T114102Z
LAST-MODIFIED:20230822T114159Z
UID:37658-1701129600-1701388799@www.pharmajournalist.com
SUMMARY:Donor Selection & Cell Source Summit 2023
DESCRIPTION:The Donor Selection & Cell Source Summit is your ultimate platform to explore the latest global regulatory requirements and differences on donor testing\, understand the novel genome sequencing data being used to inform donor selection\, and forge new partnerships to ease logistical coordination with donation sites to ensure exclusive availability of selected donor pools. \nJoin Senti Biosciences\, Poseida Therapeutics\, Caribou Bio\, Allogene and more to advance your knowledge on donor selection\, management and sustainability to ensure a consistent and reliable supply of cell source material required for clinical trials and beyond. \nDownload a copy of the event guide to view the 3-day jam-packed agenda\, expert speaker faculty and exclusive pre-conference workshop day: https://ter.li/t81hko
URL:https://www.pharmajournalist.com/event/donor-selection-cell-source-summit-2023/
LOCATION:The Clift Royal Sonesta\, 495 Geary Street\, San Francisco\, CA\, 94102\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231128
DTEND;VALUE=DATE:20231201
DTSTAMP:20260516T075559
CREATED:20230825T133450Z
LAST-MODIFIED:20230825T133450Z
UID:37674-1701129600-1701388799@www.pharmajournalist.com
SUMMARY:4th Annual CRISPR 2.0 Congress 2023
DESCRIPTION:CRISPR represents the next frontier in the cell and gene therapy landscape. Spearheaded by the first gene edited therapeutic awaiting FDA approval\, a mounting wave of innovative technology developments and therapeutic applications are leading to a paradigm shift in our global healthcare systems. \nTo this end\, the 4th Annual CRISPR 2.0 Congress is your definitive guide to showcasing the latest and greatest CRISPR tools being developed and applied in the therapeutic setting. \nTo know more visit: https://ter.li/rqwuyn
URL:https://www.pharmajournalist.com/event/4th-annual-crispr-2-0-congress-2023/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231128
DTEND;VALUE=DATE:20231201
DTSTAMP:20260516T075559
CREATED:20230829T091427Z
LAST-MODIFIED:20230829T091427Z
UID:37688-1701129600-1701388799@www.pharmajournalist.com
SUMMARY:Advanced Purification for Complex Biologics Summit
DESCRIPTION:The Advanced Purification for Complex Biologics Summit is the first and only standalone conference focused on purification for biologics and novel modalities bringing together purification\, CMC and MSAT professionals to collaborate and remove purification bottlenecks to meet market delivery timelines. \nThis in-depth 3-day event will feature the latest breakthroughs and cutting-edge content in AI and digital learning tools to help you save time during downstream processing and boost efficiency. \nThis is your unique opportunity to meet 60+ purification and downstream processing experts including Sanofi\, Takeda\, Eli Lilly\, AstraZeneca and Regeneron as they talk you through machine learning\, predictive modelling\, and consumables advancements to empower your process optimization\, moving a step closer to 100% product purity. \nTo know more visit: https://ter.li/80pxjz
URL:https://www.pharmajournalist.com/event/advanced-purification-for-complex-biologics-summit/
LOCATION:Sonesta Philadelphia Rittenhouse Square\, 1800 Market Street\, Philadelphia\, PA\, 19103\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR